Literature DB >> 22879576

Cancer-specific concerns and physical activity among recently diagnosed breast and prostate cancer survivors.

Allison Ottenbacher1, Richard Sloane, Denise C Snyder, William Kraus, Lisa Sprod, Wendy Demark-Wahnefried.   

Abstract

BACKGROUND: Cancer treatment -related side effects may have a negative impact on quality of life among cancer survivors and may limit participation in physical activity (PA). HYPOTHESIS: Cancer-specific concerns will be reduced throughout a 10-month diet and exercise intervention among recently diagnosed cancer survivors. Additionally, participants reporting greater levels of PA will also report fewer cancer-specific concerns. STUDY
DESIGN: This study is an exploratory analysis of 452 recently diagnosed, early-stage breast and prostate cancer survivors who participated in the FRESH START diet and exercise trial. Data were collected at baseline and 1-year follow-up.
RESULTS: At baseline, chief concerns among prostate cancer survivors included ability to have an erection (mean score [standard deviation] = 1.0 [1.3]) and urinary frequency (2.5 [1.4]), whereas among breast cancer survivors, eminent concerns were not feeling sexually attractive (2.0 [1.3]) and worry about cancer in other members of their family (2.1 [1.3]). At 1 year, there was a significant improvement in cancer-specific concerns on breast cancer-specific concerns (P < .01) but not on prostate cancer-specific concerns. At baseline, women who were self-conscious about their dress had higher levels of PA, whereas men reporting issues with incontinence reported lesser increases in PA in response to the intervention.
CONCLUSION: Cancer-specific concerns diminish over time, especially among breast cancer survivors. Among prostate cancer survivors, incontinence is a significant barrier that hinders benefit from PA interventions. Thus, there is a need either for medical interventions to ameliorate incontinence or for behavioral interventions to address this issue among survivors.

Entities:  

Mesh:

Year:  2012        PMID: 22879576      PMCID: PMC3764991          DOI: 10.1177/1534735412449734

Source DB:  PubMed          Journal:  Integr Cancer Ther        ISSN: 1534-7354            Impact factor:   3.279


  24 in total

1.  Prostate cancer: how assessment of QoL can improve delivery of care.

Authors:  Michelle Brown
Journal:  Br J Nurs       Date:  2010 Sep 23-Oct 13

2.  Estimating clinically meaningful changes for the Functional Assessment of Cancer Therapy--Prostate: results from a clinical trial of patients with metastatic hormone-refractory prostate cancer.

Authors:  David Cella; Michael B Nichol; David Eton; Joel B Nelson; Parvez Mulani
Journal:  Value Health       Date:  2008-07-18       Impact factor: 5.725

3.  Lymphedema and quality of life in survivors of early-stage breast cancer.

Authors:  Sarah M Beaulac; Lindsay A McNair; Thayer E Scott; Wayne W LaMorte; Maureen T Kavanah
Journal:  Arch Surg       Date:  2002-11

4.  Quality of life in breast cancer patients--not enough attention for long-term survivors?

Authors:  B Holzner; G Kemmler; M Kopp; R Moschen; H Schweigkofler; M Dünser; R Margreiter; W W Fleischhacker; B Sperner-Unterweger
Journal:  Psychosomatics       Date:  2001 Mar-Apr       Impact factor: 2.386

5.  Assessment of habitual physical activity by a seven-day recall in a community survey and controlled experiments.

Authors:  S N Blair; W L Haskell; P Ho; R S Paffenbarger; K M Vranizan; J W Farquhar; P D Wood
Journal:  Am J Epidemiol       Date:  1985-11       Impact factor: 4.897

6.  Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.

Authors:  M J Brady; D F Cella; F Mo; A E Bonomi; D S Tulsky; S R Lloyd; S Deasy; M Cobleigh; G Shiomoto
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

7.  Associations of physical activity with quality of life and functional ability in breast cancer patients during active adjuvant treatment: the Pathways Study.

Authors:  Jeanne S Mandelblatt; Gheorghe Luta; Marilyn L Kwan; Solomon B Makgoeng; Isaac J Ergas; Janise M Roh; Barbara Sternfeld; Lucile L Adams-Campbell; Lawrence H Kushi
Journal:  Breast Cancer Res Treat       Date:  2011-04-08       Impact factor: 4.872

8.  Extant health behaviors and uptake of standardized vs tailored health messages among cancer survivors enrolled in the FRESH START trial: a comparison of fighting-spirits vs fatalists.

Authors:  Anna V Wilkinson; Stephanie L Barrera; Colleen M McBride; Denise C Snyder; Richard Sloane; Karen M Meneses; Dorothy Pekmezi; William E Kraus; Wendy Demark-Wahnefried
Journal:  Psychooncology       Date:  2010-11-08       Impact factor: 3.894

9.  Design of FRESH START: a randomized trial of exercise and diet among cancer survivors.

Authors:  Wendy Demark-Wahnefried; Elizabeth C Clipp; Colleen McBride; David F Lobach; Isaac Lipkus; Bercedis Peterson; Denise Clutter Snyder; Richard Sloane; Jennifer Arbanas; William E Kraus
Journal:  Med Sci Sports Exerc       Date:  2003-03       Impact factor: 5.411

10.  Quality of life and sexuality of men with prostate cancer 3 years after cryosurgery.

Authors:  John W Robinson; Bryan J Donnelly; John C Saliken; Bryce A Weber; Scott Ernst; John C Rewcastle
Journal:  Urology       Date:  2002-08       Impact factor: 2.649

View more
  13 in total

1.  Grasping the 'teachable moment': time since diagnosis, symptom burden and health behaviors in breast, colorectal and prostate cancer survivors.

Authors:  Shirley M Bluethmann; Karen Basen-Engquist; Sally W Vernon; Matthew Cox; Kelley Pettee Gabriel; Sandra A Stansberry; Cindy L Carmack; Janice A Blalock; Wendy Demark-Wahnefried
Journal:  Psychooncology       Date:  2015-06-08       Impact factor: 3.894

2.  Sexuality and exercise in men undergoing androgen deprivation therapy for prostate cancer.

Authors:  K Hamilton; S K Chambers; M Legg; J L Oliffe; P Cormie
Journal:  Support Care Cancer       Date:  2014-07-10       Impact factor: 3.603

3.  Representations of cancer recurrence risk, recurrence worry, and health-protective behaviours: an elaborated, systematic review.

Authors:  Arturo Durazo; Linda D Cameron
Journal:  Health Psychol Rev       Date:  2019-06-03

Review 4.  Conservative management for postprostatectomy urinary incontinence.

Authors:  Coral A Anderson; Muhammad Imran Omar; Susan E Campbell; Kathleen F Hunter; June D Cody; Cathryn M A Glazener
Journal:  Cochrane Database Syst Rev       Date:  2015-01-20

5.  Pre-diagnostic allostatic load and health-related quality of life in a cohort of Black breast cancer survivors.

Authors:  Cathleen Y Xing; Michelle Doose; Bo Qin; Yong Lin; Tiffany L Carson; Jesse J Plascak; Kitaw Demissie; Chi-Chen Hong; Elisa V Bandera; Adana A M Llanos
Journal:  Breast Cancer Res Treat       Date:  2020-09-10       Impact factor: 4.872

Review 6.  Exercise therapy for sexual dysfunction after prostate cancer.

Authors:  Prue Cormie; Robert U Newton; Dennis R Taaffe; Nigel Spry; Daniel A Galvão
Journal:  Nat Rev Urol       Date:  2013-10-08       Impact factor: 14.432

Review 7.  Benefits and Barriers of Cancer Practitioners Discussing Physical Activity with their Cancer Patients.

Authors:  Justin W L Keogh; Alicia Olsen; Michael Climstein; Sally Sargeant; Lynnette Jones
Journal:  J Cancer Educ       Date:  2017-03       Impact factor: 2.037

8.  Development of a computer-tailored physical activity intervention for prostate and colorectal cancer patients and survivors: OncoActive.

Authors:  R H J Golsteijn; C Bolman; E Volders; D A Peels; H de Vries; L Lechner
Journal:  BMC Cancer       Date:  2017-06-26       Impact factor: 4.430

9.  Physician role in physical activity for African-American males undergoing radical prostatectomy for prostate cancer.

Authors:  Faustine Williams; Kellie R Imm; Graham A Colditz; Ashley J Housten; Lin Yang; Keon L Gilbert; Bettina F Drake
Journal:  Support Care Cancer       Date:  2016-12-21       Impact factor: 3.603

10.  Current nutrition promotion, beliefs and barriers among cancer nurses in Australia and New Zealand.

Authors:  Petra G Puhringer; Alicia Olsen; Mike Climstein; Sally Sargeant; Lynnette M Jones; Justin W L Keogh
Journal:  PeerJ       Date:  2015-11-10       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.